Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Outcomes Among Racial and Ethnic Minority Patients With Advanced Cancers in Phase 1 Trials

JAMA Network Open(2024)10.1001/jamanetworkopen.2024.21485Source: DataRank Database

Outcomes Among Racial and Ethnic Minority Patients With Advanced Cancers in Phase 1 Trials is a research paper published in JAMA Network Open (2024). On theSindex it has a DataRank of 0. It has been cited 4 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access4 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 1.63)OA: goldTopics (60)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Abdissa Negassa ORCID,Mohammad H. Ghalib,Imran Chaudhary ORCID,Kavita Desai ORCID,Umang Shah ORCID

Live enrichment

PubMed:38990570 PMC:PMC11240188 OpenAlex:https://openalex.org/W4400534686

NIA NIH HHS

Grant: R21 AG058027

National Institutes of Health

Grant: 1R21AG058027-01

COMPARATIVE EFFECTIVENESS OF BIOLOGIC AGENTS IN ETHNIC MINORITIES WITH COLORECTAL CANCER

FWCI

1.63

Citation Percentile

0.8%

Citation Trend

2024

2025

2026

goldLicense: cc-by

journalhttps://jamanetwork.com/journals/jamanetworkopen/articlepdf/2821085/goel_2024_oi_240680_1720011861.40659.pdf

publisherhttps://jamanetwork.com/journals/jamanetworkopen/articlepdf/2821085/goel_2024_oi_240680_1720011861.40659.pdf

journalhttps://doi.org/10.1001/jamanetworkopen.2024.21485

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38990570

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/11240188

Fields of Study

Ethics in Clinical ResearchStatistical Methods in Clinical TrialsBRCA gene mutations in cancer03 medical and health sciences0302 clinical medicineAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedYoung AdultBlack or African AmericanClinical Trials, Phase I as TopicEthnic and Racial MinoritiesHispanic or LatinoNeoplasmsTreatment OutcomeAsianWhite

MeSH Terms

Ethnic and Racial MinoritiesWhiteAdultAgedAged, 80 and overAsianBlack or African AmericanFemaleHispanic or LatinoHumansMaleMiddle AgedNeoplasmsTreatment OutcomeClinical Trials, Phase I as TopicYoung Adult

Keywords

MedicineClinical trialInternal medicineGuidelineCancerPathologyAdultAged, 80 and overMaleClinical Trials, Phase I as TopicAsianWhiteHispanic or LatinoMiddle AgedBlack or African AmericanYoung AdultTreatment OutcomeNeoplasmsEthnic and Racial MinoritiesHumansFemaleOriginal InvestigationAged

Sustainable Development Goals

SDG 0: Good health and well-being

Outcomes Among Racial and Ethnic Minority Patients With Advanced Cancers in Phase 1 Trials

FAIR Checklist

Authors (10)

Funding (2 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)